K. Herold

Clinical and molecular heterogeneity of familial hyperinsulinism.

C. Stanley, B. Glaser, P. Thornton, 1998, The Journal of pediatrics.

Familial hyperinsulinism caused by an activating glucokinase mutation.

F M Matschinsky, M. Permutt, C. Stanley, 1998, The New England journal of medicine.

The rise and fall of insulin secretion in type 1 diabetes mellitus

F. T. E. Group, J. Palmer, N. Sherry, 2006, Diabetologia.

Familial hyperinsulinism with apparent autosomal dominant inheritance: clinical and genetic differences from the autosomal recessive variant.

M. Permutt, C. Stanley, B. Glaser, 1998, The Journal of pediatrics.

The Effect of Ethnicity in the Rate of Beta Cell Functional Loss in the First 3 Years After Type 1 Diabetes Diagnosis.

Kathleen C. Fraser, Mark S. Anderson, Renee A. Davis, 2020, The Journal of clinical endocrinology and metabolism.

Treatment of type 1 diabetes with anti-CD3 monoclonal antibody

K. Herold, Kaven C. Herold, L. Taylor, 2003, Immunologic research.